TABLE OF CONTENTS

1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. South & Central America Human Vaccine Adjuvants Market - Key Market Dynamics

4.1 South & Central America Human Vaccine Adjuvants Market - Key Market Dynamics

4.2 Market Drivers

4.2.1 Rising Prevalence of Chronic Diseases

4.2.2 Growing Focus on Immunization Programs

4.3 Market Restraints

4.3.1 Manufacturing Complexities and Regulatory Challenges

4.4 Market Opportunities

4.4.1 Growing Pharmaceutical Industry

4.5 Future Trends

4.5.1 Rising Trend of Personalized Vaccines

4.6 Impact of Drivers and Restraints:

5. Human Vaccine Adjuvants Market - South & Central America Market Analysis

5.1 South & Central America Human Vaccine Adjuvants Market Revenue (US$ Million), 2020 - 2030

5.2 South & Central America Human Vaccine Adjuvants Market Forecast Analysis

6. South & Central America Human Vaccine Adjuvants Market Analysis - by Type

6.1 Particulate Adjuvant

6.1.1 Overview

6.1.2 Particulate Adjuvant: South & Central America Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)

6.2 Emulsion Adjuvant

6.2.1 Overview

6.2.2 Emulsion Adjuvant: South & Central America Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)

6.3 Combination Adjuvant

6.3.1 Overview

6.3.2 Combination Adjuvant: South & Central America Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)

6.4 Others

6.4.1 Overview

6.4.2 Others: South & Central America Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)

7. South & Central America Human Vaccine Adjuvants Market Analysis - by Application

7.1 Influenza

7.1.1 Overview

7.1.2 Influenza: South & Central America Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)

7.2 Hepatitis

7.2.1 Overview

7.2.2 Hepatitis: South & Central America Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)

7.3 Human papilloma virus (HPV)

7.3.1 Overview

7.3.2 Human papilloma virus (HPV): South & Central America Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)

7.4 Others

7.4.1 Overview

7.4.2 Others: South & Central America Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)

8. South & Central America Human Vaccine Adjuvants Market Analysis - by End User

8.1 Pharmaceutical and Biotechnology Companies

8.1.1 Overview

8.1.2 Pharmaceutical and Biotechnology Companies: South & Central America Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)

8.2 CMOs and CROs

8.2.1 Overview

8.2.2 CMOs and CROs: South & Central America Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)

8.3 Others

8.3.1 Overview

8.3.2 Others: South & Central America Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)

9. South & Central America Human Vaccine Adjuvants Market - Country Analysis

9.1 South & Central America

9.1.1 South & Central America Human Vaccine Adjuvants Market Breakdown, by Key Countries, 2022 and 2030 (%)

9.1.1.1 Brazil Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)

9.1.1.1.1 Brazil Human Vaccine Adjuvants Market Breakdown, by Type

9.1.1.1.2 Brazil Human Vaccine Adjuvants Market Breakdown, by Application

9.1.1.1.3 Brazil Human Vaccine Adjuvants Market Breakdown, by End User

9.1.1.2 Argentina Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)

9.1.1.2.1 Argentina Human Vaccine Adjuvants Market Breakdown, by Type

9.1.1.2.2 Argentina Human Vaccine Adjuvants Market Breakdown, by Application

9.1.1.2.3 Argentina Human Vaccine Adjuvants Market Breakdown, by End User

9.1.1.3 Rest of South & Central America Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)

9.1.1.3.1 Rest of South & Central America Human Vaccine Adjuvants Market Breakdown, by Type

9.1.1.3.2 Rest of South & Central America Human Vaccine Adjuvants Market Breakdown, by Application

9.1.1.3.3 Rest of South & Central America Human Vaccine Adjuvants Market Breakdown, by End User

10. Industry Landscape

10.1 Overview

11. Company Profiles

11.1 Novartis AG

11.1.1 Key Facts

11.1.2 Business Description

11.1.3 Products and Services

11.1.4 Financial Overview

11.1.5 SWOT Analysis

11.1.6 Key Developments

11.2 CSL Ltd

11.2.1 Key Facts

11.2.2 Business Description

11.2.3 Products and Services

11.2.4 Financial Overview

11.2.5 SWOT Analysis

11.2.6 Key Developments

11.3 Seppic SA

11.3.1 Key Facts

11.3.2 Business Description

11.3.3 Products and Services

11.3.4 Financial Overview

11.3.5 SWOT Analysis

11.3.6 Key Developments

11.4 Croda International Plc

11.4.1 Key Facts

11.4.2 Business Description

11.4.3 Products and Services

11.4.4 Financial Overview

11.4.5 SWOT Analysis

11.4.6 Key Developments

11.5 Novavax Inc

11.5.1 Key Facts

11.5.2 Business Description

11.5.3 Products and Services

11.5.4 Financial Overview

11.5.5 SWOT Analysis

11.5.6 Key Developments

11.6 Phibro Animal Health Corp

11.6.1 Key Facts

11.6.2 Business Description

11.6.3 Products and Services

11.6.4 Financial Overview

11.6.5 SWOT Analysis

11.6.6 Key Developments

12. Appendix

12.1 About The Insight Partners

12.2 Glossary of Terms

List of Tables

Table 1. South & Central America Human Vaccine Adjuvants Market Segmentation

Table 2. South & Central America Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)

Table 3. South & Central America Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million) - by Type

Table 4. South & Central America Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million) - by Application

Table 5. South & Central America Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million) - by End User

Table 6. Brazil Human Vaccine Adjuvants Market - Revenue and Forecast to 2030(US$ Million) - by Type

Table 7. Brazil Human Vaccine Adjuvants Market - Revenue and Forecast to 2030(US$ Million) - by Application

Table 8. Brazil Human Vaccine Adjuvants Market - Revenue and Forecast to 2030(US$ Million) - by End User

Table 9. Argentina Human Vaccine Adjuvants Market - Revenue and Forecast to 2030(US$ Million) - by Type

Table 10. Argentina Human Vaccine Adjuvants Market - Revenue and Forecast to 2030(US$ Million) - by Application

Table 11. Argentina Human Vaccine Adjuvants Market - Revenue and Forecast to 2030(US$ Million) - by End User

Table 12. Rest of South & Central America Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million) - by Type

Table 13. Rest of South & Central America Human Vaccine Adjuvants Market - Revenue and Forecast to 2030(US$ Million) - by Application

Table 14. Rest of South & Central America Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million) - by End User

Table 15. Recent Growth Strategies in the Human Vaccine Adjuvants Market

Table 16. Glossary of Terms, Human Vaccine Adjuvants Market

List of Figures

Figure 1. South & Central America Human Vaccine Adjuvants Market Segmentation, by Country

Figure 2. Impact Analysis of Drivers and Restraints

Figure 3. South & Central America Human Vaccine Adjuvants Market Revenue (US$ Million), 2022 - 2030

Figure 4. South & Central America Human Vaccine Adjuvants Market Share (%) - by Type (2022 and 2030)

Figure 5. Particulate Adjuvant: South & Central America Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)

Figure 6. Emulsion Adjuvant: South & Central America Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)

Figure 7. Combination Adjuvant: South & Central America Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)

Figure 8. Others: South & Central America Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)

Figure 9. South & Central America Human Vaccine Adjuvants Market Share (%) - by Application (2022 and 2030)

Figure 10. Influenza: South & Central America Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)

Figure 11. Hepatitis: South & Central America Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)

Figure 12. Human papilloma virus (HPV): South & Central America Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)

Figure 13. Others: South & Central America Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)

Figure 14. South & Central America Human Vaccine Adjuvants Market Share (%) - by End User (2022 and 2030)

Figure 15. Pharmaceutical and Biotechnology Companies: South & Central America Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)

Figure 16. CMOs and CROs: South & Central America Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)

Figure 17. Others: South & Central America Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)

Figure 18. South & Central America Human Vaccine Adjuvants Market Breakdown, by Key Countries - Revenue (2022) (US$ Million)

Figure 19. South & Central America Human Vaccine Adjuvants Market Breakdown, by Key Countries, 2022 and 2030 (%)

Figure 20. Brazil Human Vaccine Adjuvants Market - Revenue and Forecast to 2030(US$ Million)

Figure 21. Argentina Human Vaccine Adjuvants Market - Revenue and Forecast to 2030(US$ Million)

Figure 22. Rest of South & Central America Human Vaccine Adjuvants Market - Revenue and Forecast to 2030(US$ Million)